← Back to news
S

Seeking Alpha: News

JPMorgan US Ultra-Short Income Active ETF declares CAD 0.0743 dividend

B

Arch Capital outlines capital deployment priorities with $1.9B buybacks and signals stable catastrophe loss outlook for 2026

B

S&P Global signals 6–8% organic revenue growth for 2026 as subscription momentum builds

B

Coca-Cola expects 4–5% organic revenue growth for 2026 while advancing innovation and refranchising

B

Bed Bath & Beyond rallies on ChatGPT ads pilot inclusion

B

Zimmer Biomet outlines 2026 revenue growth of 1%–3% amid U.S. sales force overhaul and innovation cycle

B

S&P 500, Nasdaq drift lower after the latest retail sales data

B

Tesla sales exec departs as company shifts gears to robots

B

The Fed's current rate may be close to neutral, Dallas Fed's Logan says

B

Top Quant rated insurance brokers amid AI disruption fears

B

Germany is said to ready $638M order for flying attack drones

B

Market Voices: Paramount-WBD bid, Holtec IPO, AstraZeneca

B

Ark Restaurants signals cash position improvement as America build-out nears completion

B

Masco hits 52-week high as earnings top estimates; $2B buyback, job cuts

B

Kongsberg Gruppen ASA reports FY2025 results

B

Moderna to supply respiratory vaccines to Mexico as part of five-year deal

B

McDonald's Q4 earnings on deck: What to expect

B

Axalta targets $1.14B–$1.17B adjusted EBITDA in 2026 as merger with AkzoNobel advances

B

Coloplast A/S reports Q1 results

B

Treasury yields slide after retail sales disappoint, boosting Fed-cut bets

B

Incyte falls as Q4 results, 2026 revenue guidance disappoint

B

DLH outlines plans for debt reduction and margin improvement amid federal budget clarity

B

Figma leaps 10%, erasing some year-to-date losses as Q4 earnings approach

B

Coca-Cola's post-earnings decline is due to psychology, not fundamentals - SA analyst

B

Rising capex for the Mag 7 may be a catalyst for them to underperform the market – analyst

B

Medpace outlines 2026 revenue growth of up to 12.8% amid backlog normalization and metabolic trial shifts

B

Lee Enterprises outlines $450M digital revenue target by 2030 following $50M equity investment and interest rate reduction

B

Cleveland Fed's Hammack says rates may stay on hold 'for quite some time'

B

India's second-largest automaker selects Mobileye's ADAS for six new models

B

Probability of recession remains low; the Fed is positioned to support markets – Evercore ISI’s Emanuel

B

Manitowoc outlines $2.25B–$2.35B 2026 sales target amid CRANES+50 strategy expansion and robust tower crane demand

B

Shell CEO says no need to buy assets anytime soon, as near-term shortfall largely covered

B

Xylem outlines 2026 revenue guidance of $9.1B–$9.2B with margin expansion driven by portfolio simplification

S

DuPont targets 3% organic sales growth and $2.25–$2.30 EPS for 2026 as portfolio transformation accelerates

S

Personalis rises on Medicare coverage for NeXT Personal cancer test

S

First Merchants declares $0.36 dividend

S

BorgWarner Q4 2025 Earnings Preview

S

Hilton Worldwide Q4 2025 Earnings Preview

S

SiteOne Landscape Q4 2025 Earnings Preview

S

SA analyst upgrades/downgrades: TSLA, MRK, CRWD, STLA

S

Hasbro and Warner Bros. expect a Harry Potter boost from the new series

S

Inter & Co Q4 2025 Earnings Preview

S

Equinor plans to boost international oil and gas production by 2030

S

Blackbaud targets 13%+ EPS CAGR through 2030 with aggressive AI rollout and 50%+ free cash flow for buybacks

S

Small businesses see no capex boom

S

The Chefs' Warehouse Q4 2025 Earnings Preview

S

Radcom Q4 2025 Earnings Preview

S

SharkNinja Q4 2025 Earnings Preview

S

Medpace slumps after Q4 earnings on book-to-bill ratio

S

Penske Automotive Q4 2025 Earnings Preview

S